Kimbrough Orvin T

Director · CNM

As of 2026-09-16, Kimbrough Orvin T has 10 Form 4 transactions on record across 1 company — 1 in the trailing 12 months.

Everything this person has disclosed to the SEC on Form 4 — across every company they file for — reconstructed from the public record. A filing history, not a tip sheet.

Reconstructed holdings

Direct: $718KIndirect: $1.2M$1.9Mas of 2026-09-16
  • Direct $718K
  • Indirect $1.2M
CNMindirect28,709 sh$1.2M
CNMdirect16,757 sh$718K

Reconstructed from this person's own Form 4 filings — the total each filing reported owning afterward, priced at the close on the as-of date shown. A filed position can lag the real one.

Direct and indirect holdings (e.g. through a trust or fund) are tagged separately, as filed.

Trades by company

CNM · 10 trades
2026-06-23: Award / grant, 2,799 sh ($0)2025-07-18: Sale, 23,962 sh ($1.5M)2025-07-18: Other acquisition, 5 sh ($0)2025-07-18: Conversion, 23,957 sh ($0)2025-07-18: Other acquisition, 23,957 sh ($0)2025-07-18: Conversion, 23,957 sh ($0)2025-07-18: Withheld for tax, 1,038 sh ($0)2025-07-18: Other acquisition, 23,957 sh ($0)2025-07-18: Other acquisition, 5 sh ($0)2025-06-24: Award / grant, 2,189 sh ($0)

Filing ledger

DateCompanyActionShares @ priceValueOwnership ΔOwned afterFiling
2025-07-18CNMSale23,962 @ $61.77$1.5M−63.2% of holding13,958Form 4
9 award / exercise / gift records — not counted as purchases
DateCompanyActionSharesOwned afterFiling
2026-06-23CNMAward / grant2,79916,757Form 4
2025-07-18CNMOther acquisition513,963Form 4
2025-07-18CNMConversion23,95737,920Form 4
2025-07-18CNMOther acquisition23,95723,957Form 4
2025-07-18CNMConversion23,9570Form 4
2025-07-18CNMWithheld for tax1,03828,709Form 4
2025-07-18CNMOther acquisition23,95729,747Form 4
2025-07-18CNMOther acquisition53Form 4
2025-06-24CNMAward / grant2,18913,958Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.